Christopher C Mayer
Overview
Explore the profile of Christopher C Mayer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
498
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iatridi F, Theodorakopoulou M, Georgiou A, Karagiannidis A, Haddad N, Devrikis N, et al.
J Hum Hypertens
. 2024 Sep;
38(12):789-795.
PMID: 39251749
Male patients with pre-dialysis chronic kidney disease (CKD) have worse ambulatory blood pressure (BP) control than females; this is associated with higher mortality. Male hemodialysis patients have higher ambulatory BP...
2.
Mayer C, Sarafidis P, Matschkal J, Theodorakopoulou M, Lorenz G, Karagiannidis A, et al.
Clin Kidney J
. 2024 Jul;
17(7):sfae172.
PMID: 39056069
Background: Risk prediction in haemodialysis (HD) patients is challenging due to the impact of the dialysis regime on the patient's volume status and the complex interplay with cardiac function, comorbidities...
3.
Hametner B, Maurer S, Sehnert A, Bachler M, Orter S, Zechner O, et al.
Physiol Meas
. 2024 Apr;
45(5).
PMID: 38688296
Non-invasive continuous blood pressure (BP) monitoring is of longstanding interest in various cardiovascular scenarios. In this context, pulse arrival time (PAT), i.e., a surrogate parameter for systolic BP (change), became...
4.
Pucci G, Grillo A, Dalakleidi K, Fraenkel E, Gkaliagkousi E, Golemati S, et al.
J Clin Med
. 2024 Apr;
13(5).
PMID: 38592046
Atrial fibrillation (AF), the most common cardiac arrhythmia, is associated with adverse CV outcomes. Vascular aging (VA), which is defined as the progressive deterioration of arterial function and structure over...
5.
Martina M, Park C, Alastruey J, Bruno R, Climie R, Dogan S, et al.
Expert Rev Med Devices
. 2024 Apr;
21(4):335-347.
PMID: 38557297
Background: Regulation has a key role for medical devices throughout their lifecycle aiming to guarantee effectiveness and safety for users. Requirements of Regulation (EU) 2017/745 (MDR) have an impact on...
6.
Spronck B, Terentes-Printzios D, Avolio A, Boutouyrie P, Guala A, Jeroncic A, et al.
Hypertension
. 2023 Nov;
81(1):183-192.
PMID: 37975229
Background: Arterial stiffness, as measured by arterial pulse wave velocity (PWV), is an established biomarker for cardiovascular risk and target-organ damage in individuals with hypertension. With the emergence of new...
7.
Waller M, Krenn S, Mussnig S, Schmiedecker M, Niknam-Saeidi J, Mayer C, et al.
Nephrol Dial Transplant
. 2023 Sep;
39(3):550-552.
PMID: 37708039
No abstract available.
8.
Letz T, Horandtner C, Braunisch M, Gundel P, Matschkal J, Bachler M, et al.
Physiol Meas
. 2023 Jun;
44(7).
PMID: 37336235
Left ventricular hypertrophy (LVH) is one of the most severe risk factors in patients with end-stage kidney disease (ESKD) regarding all-cause and cardiovascular mortality. It contributes to the risk of...
9.
Panayiotou A, Park C, Climie R, Mayer C, Pucci G, Bianchini E, et al.
J Hypertens
. 2023 May;
41(6):1054-1056.
PMID: 37139698
No abstract available.
10.
Alastruey J, Charlton P, Bikia V, Paliakaite B, Hametner B, Bruno R, et al.
Am J Physiol Heart Circ Physiol
. 2023 Mar;
325(1):H1-H29.
PMID: 37000606
Arterial pulse waves (PWs) such as blood pressure and photoplethysmogram (PPG) signals contain a wealth of information on the cardiovascular (CV) system that can be exploited to assess vascular age...